Last Name


Michael Gottlieb to Randomized Controlled Trials as Topic

This is a "connection" page, showing publications Michael Gottlieb has written about Randomized Controlled Trials as Topic.

Connection Strength
  1. Gottlieb M, Khishfe B. Idarucizumab for the Reversal of Dabigatran. Ann Emerg Med. 2017 May; 69(5):554-558.
    View in: PubMed
    Score: 0.182
  2. Gottlieb M. Comparison of trimethoprim-sulfamethoxazole versus placebo for uncomplicated skin abscesses. CJEM. 2017 Jul; 19(4):308-311.
    View in: PubMed
    Score: 0.178
  3. Gottlieb M. Early goal-directed therapy versus usual care in the management of septic shock. CJEM. 2017 Jan; 19(1):65-67.
    View in: PubMed
    Score: 0.171
  4. Gottlieb M, Nakitende D. Comparison of Tamsulosin, Nifedipine, and Placebo for Ureteric Colic. CJEM. 2017 Mar; 19(2):156-158.
    View in: PubMed
    Score: 0.168
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.